PASQUINI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 1.244
AS - Asia 380
EU - Europa 372
SA - Sud America 15
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 2.016
Nazione #
US - Stati Uniti d'America 1.223
IT - Italia 181
SG - Singapore 156
CN - Cina 118
ID - Indonesia 49
DE - Germania 42
TR - Turchia 40
GB - Regno Unito 31
UA - Ucraina 22
PL - Polonia 21
CA - Canada 20
FR - Francia 19
BR - Brasile 14
CH - Svizzera 14
SE - Svezia 12
FI - Finlandia 11
BE - Belgio 7
HK - Hong Kong 6
RU - Federazione Russa 4
CZ - Repubblica Ceca 3
KR - Corea 3
LT - Lituania 3
EG - Egitto 2
EU - Europa 2
PK - Pakistan 2
TW - Taiwan 2
CO - Colombia 1
IQ - Iraq 1
IR - Iran 1
JP - Giappone 1
MX - Messico 1
NL - Olanda 1
NZ - Nuova Zelanda 1
RO - Romania 1
VN - Vietnam 1
Totale 2.016
Città #
Fairfield 165
Santa Clara 125
Singapore 121
Woodbridge 107
Chandler 104
Ashburn 82
Houston 81
Seattle 70
Cambridge 55
Ferrara 51
Jakarta 49
Wilmington 46
Ann Arbor 37
Milan 36
Shanghai 30
Izmir 28
Jacksonville 28
Princeton 27
Beijing 26
Los Angeles 25
Warsaw 20
London 14
Zurich 14
Nanjing 11
Toronto 11
San Diego 10
Falls Church 9
Munich 9
Ferrara di Monte Baldo 8
Frankfurt am Main 8
Nice 8
Boardman 7
Bologna 7
San Antonio 7
Brussels 6
Ottawa 6
Venice 6
Homburg 5
Nanchang 5
Cagliari 4
Hong Kong 4
Jiaxing 4
Mountain View 4
Redwood City 4
Aversa 3
Brno 3
Changsha 3
Des Moines 3
Florence 3
Genoa 3
New York 3
Northampton 3
Verona 3
Boston 2
Bremen 2
Buffalo 2
Changchun 2
Clifton 2
Espoo 2
Hebei 2
Helsinki 2
Islamabad 2
Missoula 2
New Bedfont 2
Norwalk 2
Pisa 2
Redmond 2
Reggio Emilia 2
Rimini 2
Saskatoon 2
Shenyang 2
Tianjin 2
Torino 2
Trieste 2
Wandsworth 2
Ankara 1
Antwerp 1
Auckland 1
Avaré 1
Belo Horizonte 1
Campina Grande 1
Canary Wharf 1
Cheboksary 1
Chicago 1
Chiswick 1
Chongqing 1
Crevalcore 1
Damanhur 1
Dearborn 1
Dong Ket 1
Entre Rios 1
Fazenda Rio Grande 1
Fenghua 1
Formiga 1
Garden City 1
Gdansk 1
Guangzhou 1
Haikou 1
Ismailia 1
Istanbul 1
Totale 1.580
Nome #
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 153
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 144
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 138
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 128
Design, Synthesis, and Pharmacological Characterization of Indol-3-ylacetamides, Indol-3-yloxoacetamides, and Indol-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists 115
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 108
Development of novel pyridazinone-based adenosine receptor ligands 93
Modifications on the amino-3,5-dicyanopyridine core to obtain multifaceted adenosine receptor ligands with antineuropathic activity 86
The role of adenosinergic system in brain ischemia 80
Amino-3, 5-dicyanopyridines targeting the adenosine receptors ranging from pan ligands to combined A1/A2B partial agonists 68
Structural investigation on thiazolo[5,4-d]pyrimidines to obtain dual-acting blockers of CD73 and adenosine A2A receptor as potential antitumor agents 56
The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A1AR Positive Allosteric Modulation 56
Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1and A2A adenosine receptor antagonists/inverse agonists 55
Structure-activity relationship studies and pharmacological characterization of N5-heteroarylalkyl-substituted-2-(2-furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine-based derivatives as inverse agonists at human A2Aadenosine receptor 51
A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma 51
A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic? 49
Adenosinergic System Involvement in Ischemic Stroke Patients' Lymphocytes 46
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease 43
Adenosine and inflammation: Here, there and everywhere 42
Pulsed Electromagnetic Field Stimulation in Osteogenesis and Chondrogenesis: Signaling Pathways and Therapeutic Implications 41
Targeting adenosine receptors: A potential pharmacological avenue for acute and chronic pain 37
Piperazine-and piperidine-containing thiazolo[5,4-d]pyrimidine derivatives as new potent and selective adenosine a2a receptor inverse agonists 37
An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment? 37
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity? 34
Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer's Disease 32
4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives 32
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets 32
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition 29
Pulsed electromagnetic fields stimulate hif-1α-independent vegf release in 1321n1 human astrocytes protecting neuron-like sh-sy5y cells from oxygen-glucose deprivation 28
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? 27
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications 23
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 23
Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy 22
Synthesis of Unsymmetrical Squaramides as Allosteric GSK-3β Inhibitors Promoting β-Catenin-Mediated Transcription of TCF/LEF in Retinal Pigment Epithelial Cells 21
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors 18
Pharmacology of Adenosine Receptors: Recent Advancements 18
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence 15
2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A1 Adenosine Receptor Positive Allosteric Modulators 14
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study 14
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents 13
Effect of Low-Frequency, Low-Energy Pulsed Electromagnetic Fields in Neuronal and Microglial Cells Injured with Amyloid-Beta 12
Totale 2.121
Categoria #
all - tutte 16.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.372


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020158 0 0 0 0 0 25 33 26 27 21 18 8
2020/2021347 9 8 5 14 17 23 86 48 30 58 39 10
2021/2022228 10 14 13 0 5 17 27 20 16 18 44 44
2022/2023286 29 48 4 27 23 20 43 22 24 9 23 14
2023/2024235 17 14 9 6 38 13 11 24 7 13 10 73
2024/2025541 39 62 116 58 127 139 0 0 0 0 0 0
Totale 2.121